Once within the tumor microenvironment, PSMA targeted NBs are expected to accumulate within the tumor tissue and bind to the PSMA receptor, which will, in turn, slowly increase their accumulation in tumor cells. This evidence concerns the gene FOLH1 and neoplasm.